Literature DB >> 27788951

Magnetic Resonance Image Guided Radiation Therapy for External Beam Accelerated Partial-Breast Irradiation: Evaluation of Delivered Dose and Intrafractional Cavity Motion.

Sahaja Acharya1, Benjamin W Fischer-Valuck1, Thomas R Mazur1, Austen Curcuru1, Karl Sona1, Rojano Kashani1, Olga Green1, Laura Ochoa1, Sasa Mutic1, Imran Zoberi1, H Harold Li1, Maria A Thomas2.   

Abstract

PURPOSE: To use magnetic resonance image guided radiation therapy (MR-IGRT) for accelerated partial-breast irradiation (APBI) to (1) determine intrafractional motion of the breast surgical cavity; and (2) assess delivered dose versus planned dose. METHODS AND MATERIALS: Thirty women with breast cancer (stages 0-I) who underwent breast-conserving surgery were enrolled in a prospective registry evaluating APBI using a 0.35-T MR-IGRT system. Clinical target volume was defined as the surgical cavity plus a 1-cm margin (excluding chest wall, pectoral muscles, and 5 mm from skin). No additional margin was added for the planning target volume (PTV). A volumetric MR image was acquired before each fraction, and patients were set up to the surgical cavity as visualized on MR imaging. To determine the delivered dose for each fraction, the electron density map and contours from the computed tomography simulation were transferred to the pretreatment MR image via rigid registration. Intrafractional motion of the surgical cavity was determined by applying a tracking algorithm to the cavity contour as visualized on cine MR.
RESULTS: Median PTV volume was reduced by 52% when using no PTV margin compared with a 1-cm PTV margin used conventionally. The mean (± standard deviation) difference between planned and delivered dose to the PTV (V95) was 0.6% ± 0.1%. The mean cavity displacement in the anterior-posterior and superior-inferior directions was 0.6 ± 0.4 mm and 0.6 ± 0.3 mm, respectively. The mean margin required for at least 90% of the cavity to be contained by the margin for 90% of the time was 0.7 mm (5th-95th percentile: 0-2.7 mm).
CONCLUSION: Minimal intrafractional motion was observed, and the mean difference between planned and delivered dose was less than 1%. Assessment of efficacy and cosmesis of this MR-guided APBI approach is under way.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27788951     DOI: 10.1016/j.ijrobp.2016.08.006

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

Review 1.  Adaptive radiation dose escalation in rectal adenocarcinoma: a review.

Authors:  Jonathan D Van Wickle; Eric S Paulson; Jerome C Landry; Beth A Erickson; William A Hall
Journal:  J Gastrointest Oncol       Date:  2017-10

2.  Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience.

Authors:  L E Henke; J A Contreras; O L Green; B Cai; H Kim; M C Roach; J R Olsen; B Fischer-Valuck; D F Mullen; R Kashani; M A Thomas; J Huang; I Zoberi; D Yang; V Rodriguez; J D Bradley; C G Robinson; P Parikh; S Mutic; J Michalski
Journal:  Clin Oncol (R Coll Radiol)       Date:  2018-09-07       Impact factor: 4.126

Review 3.  Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians.

Authors:  William A Hall; Eric Paulson; X Allen Li; Beth Erickson; Christopher Schultz; Alison Tree; Musaddiq Awan; Daniel A Low; Brigid A McDonald; Travis Salzillo; Carri K Glide-Hurst; Amar U Kishan; Clifton D Fuller
Journal:  CA Cancer J Clin       Date:  2021-11-18       Impact factor: 508.702

Review 4.  The transformation of radiation oncology using real-time magnetic resonance guidance: A review.

Authors:  William A Hall; Eric S Paulson; Uulke A van der Heide; Clifton D Fuller; B W Raaymakers; Jan J W Lagendijk; X Allen Li; David A Jaffray; Laura A Dawson; Beth Erickson; Marcel Verheij; Kevin J Harrington; Arjun Sahgal; Percy Lee; Parag J Parikh; Michael F Bassetti; Clifford G Robinson; Bruce D Minsky; Ananya Choudhury; Robert J H A Tersteeg; Christopher J Schultz
Journal:  Eur J Cancer       Date:  2019-10-12       Impact factor: 9.162

Review 5.  Accelerated Partial Breast Irradiation: A New Standard of Care?

Authors:  Tobias Forster; Clara Victoria Katharina Köhler; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Breast Care (Basel)       Date:  2020-02-21       Impact factor: 2.860

6.  Improved Ipsilateral Breast and Chest Wall Sparing With MR-Guided 3-fraction Accelerated Partial Breast Irradiation: A Dosimetric Study Comparing MR-Linac and CT-Linac Plans.

Authors:  Hima Bindu Musunuru; Poonam Yadav; Stephanie J Olson; Bethany M Anderson
Journal:  Adv Radiat Oncol       Date:  2021-01-22

7.  Comprehensive target geometric errors and margin assessment in stereotactic partial breast irradiation.

Authors:  Xin Zhen; Bo Zhao; Zhuoyu Wang; Robert Timmerman; Ann Spangler; Nathan Kim; Asal Rahimi; Xuejun Gu
Journal:  Radiat Oncol       Date:  2017-09-11       Impact factor: 3.481

8.  Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system.

Authors:  Benjamin W Fischer-Valuck; Lauren Henke; Olga Green; Rojano Kashani; Sahaja Acharya; Jeffrey D Bradley; Clifford G Robinson; Maria Thomas; Imran Zoberi; Wade Thorstad; Hiram Gay; Jiayi Huang; Michael Roach; Vivian Rodriguez; Lakshmi Santanam; Harold Li; Hua Li; Jessika Contreras; Thomas Mazur; Dennis Hallahan; Jeffrey R Olsen; Parag Parikh; Sasa Mutic; Jeff Michalski
Journal:  Adv Radiat Oncol       Date:  2017-06-01

Review 9.  Optimizing MR-Guided Radiotherapy for Breast Cancer Patients.

Authors:  Maureen L Groot Koerkamp; Jeanine E Vasmel; Nicola S Russell; Simona F Shaitelman; Carmel N Anandadas; Adam Currey; Danny Vesprini; Brian M Keller; Chiara De-Colle; Kathy Han; Lior Z Braunstein; Faisal Mahmood; Ebbe L Lorenzen; Marielle E P Philippens; Helena M Verkooijen; Jan J W Lagendijk; Antonetta C Houweling; H J G Desiree van den Bongard; Anna M Kirby
Journal:  Front Oncol       Date:  2020-07-28       Impact factor: 6.244

10.  Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions.

Authors:  D Reitz; G Carl; S Schönecker; M Pazos; P Freislederer; M Niyazi; U Ganswindt; F Alongi; M Reiner; C Belka; S Corradini
Journal:  Radiat Oncol       Date:  2018-07-16       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.